Drug · DIN 02404508
TECFIDERA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 12, 2013; first marketed April 12, 2013.
- Drug Identification Number (DIN)
- 02404508
- Company (DIN owner)
- Biogen Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Dimethyl fumarate L04AX07
- Class
- Human
- Record last updated
- July 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DIMETHYL FUMARATE | 120 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 3, 2013: NOC 14268New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “tecfidera”. A notice may cover another product or only some lots: read it to see what it covers.
- Tecfidera (2015-11-20)November 20, 2015 · Drugs · Product safety · Type III
- TECFIDERA (dimethyl fumarate) - Risk of Rare Brain Condition Known as Progressive Multifocal Leukoencephalopathy (PML) - For Health ProfessionalsFebruary 6, 2015 · Drugs · Product safety
- TECFIDERA (dimethyl fumarate) - Risk of Rare Brain Condition Known as Progressive Multifocal Leukoencephalopathy (PML) - For the PublicFebruary 6, 2015 · Drugs · Product safety
Other DINs named TECFIDERA
- DIN 02420201 · Marketed